Company Overview and News
Somewhat easing the tension of a trade war, China announced that it will erase the limit on foreign ownership of domestic auto ventures. This will assist foreign automakers to own factories in the country. Notably, this restriction has been in place since 1994, which limits foreign carmakers to own not more than 50% share of any local establishment. China will lift foreign ownership limit for the wider car market by 2022.
MUNICH (Reuters) - Volkswagen (VOWG_p.DE) is open to buying a majority stake in U.S. truckmaker Navistar “at some point,” it said on Monday, as the German automaker prepares its trucks business for a possible stock market listing that could help raise funds to expand.
Volkswagen is open to buying a majority stake in U.S. truckmaker Navistar "at some point," it said on Monday, as the German automaker prepares its trucks business for a possible stock market listing that could help raise funds to expand.
Hino Motors President Yoshio Shimo and Volkswagen Truck & Bus GmbH CEO Andreas Renschler shake hands as they pose for pictures during their joint news conference in Tokyo April 12, 2018. — Reuters picTOKYO, April 12 — The truck units of Toyota Motor and Volkswagen AG are forming an alliance to bolster their market positions as commercial vehicle makers face growing costs to develop lower-emission vehicles and automated driving capabilities.
Japanese truck maker Hino Motors Ltd , majority-held by Toyota Motor Corp , said on Thursday it had agreed to form a strategic tie-up with Volkswagen Truck & Bus GmbH.
Hino Motors, Toyota Motor Corp.’s group truck manufacturer, and Volkswagen Truck & Bus of Germany agreed Thursday to form a partnership on the technologies behind hybrids, electric cars, autonomous driving and connectivity.
Japan's Nikkei share average rose on Thursday morning, rebounding from a six-day losing streak and pushing most sectors into positive territory, as a weaker yen and corporate earnings helped drive the benchmark index higher. The Nikkei gained 1.4 per cent to 23,410.33 in midmorning trade, after declining for sixth straight sessions.
Global auto sales of the alliance of Nissan Motor Co., Renault SA of France and Mitsubishi Motors Corp. reached around 10.6 million units in 2017, securing the No. 2 spot for the first time, according to data released Tuesday.
TOKYO (Reuters) - The Renault-Nissan automaking alliance emerged as the world’s biggest seller of light vehicles in 2017, bumping Volkswagen AG off the top spot, after the inclusion of Mitsubishi Motors’ numbers boosted its final tally.
Commercial vehicle market leader Tata Motors has formed an alliance with Canada-based Westport Fuel Systems Inc to source Bharat Stage VI type engines for its CNG-fired range of trucks and buses.
Four automakers plan to join the electric vehicle technology development project formed by Toyota Motor Corp., Mazda Motor Corp. and Denso Corp., it was learned Sunday.
NEW DELHI – Hino Motors Ltd. has agreed to develop an advanced lower-emission diesel engine with an Indian company while utilizing the partner’s parts procurement capability.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET